Analysts expect RCM Technologies to report Q3 2026 revenue of $66.5 million and EPS of $0.27, with the current stock price of $19.85 trailing the average analyst target of $28.00. Investors are specifically watching the growth trajectory of the Specialty Health Care segment, particularly its school-based staffing contracts for the new academic year.

Strength in the Engineering division's aerospace backlog is expected to provide a tailwind, though market participants remain cautious about labor cost pressures. This report will be critical in confirming if recent operational efficiencies are translating into sustainable margin expansion across all three business units.